image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Our latest issue will be released in 9 days, don't miss out!

4Imprint - Q1 revenues up 15%

June 2012

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • FOUR
  • Price:
  • 290p
4Imprint's target to double the size of its business in five years looks well on track with group revenues rising 15% to £37.5m in the first quarter. This was mainly driven by its US-based direct marketing side, which increased revenues by 15% to £34m. Encouragingly, new orders from previously acquired customers, which enjoy higher margins, increased 21% over the prior year while new customer acquisition was also consistent with marketing activity and prior year yield.With the outlook for direct marketing remaining strong, the shares could break through £3 at any time. Keep buying.  ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X